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Abstract
The objective was to evaluate ovarian activity reversibility in domestic queens after short-term contraceptive treatment with
eslorelin acetate. Ten mature queens were used. In all queens, the estrous cycle was evaluated every 72 h by vaginal cytology
VC) and behavior assessments. When queens had VC characteristic of interestrus or diestrus, one deslorelin acetate implant (4.7
g) was placed in the subcutaneous tissue of the interscapular region (day of insertion  Day 0). Thereafter, VC was performed
very 48 h and on Day 90, implants were removed. At Day 100, estrus and ovulation were induced with 100 IU eCG (im),
ollowed by 100 IU hCG (im), 84 h later (Day 103.5). Queens were ovariohysterectomized on Day 106. Corpora lutea (CL) were
ounted, oviducts were flushed, and oocytes were identified, isolated and stained to assess viability. In all queens, blood samples
or plasma progesterone concentrations were collected once a week, from Days 21 to 106. After deslorelin acetate application,
our queens had VC and behavior typical of estrus, and one ovulated. Furthermore, ovulation occurred in three queens that did
ot have VC or behavior consistent with estrus. After the initial ovarian stimulation, all females had anestrous VC during the
eslorelin treatment period. Implants were readily removed. Following implant removal, all females responded to treatments to
nduce estrus and ovulation. There were (mean  SEM) 13.1  5.5 CL and 8.1  5.5 oocytes per queen; the oocyte recovery
ate was 56.8  25.4% and all recovered oocytes were viable. We concluded that deslorelin acetate can be used as a reversible
hort-term contraceptive in domestic cats, because estrus and ovulation were successfully induced following implant removal.
 2012 Elsevier Inc. Open access under the Elsevier OA license.
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w1. Introduction
Gonadotrophin releasing hormone (GnRH) is a de-
capeptide that belongs to a group of neuropeptides of
hypothalamic origin which control secretions of the
anterior pituitary. It is well known that GnRH influ-
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ttp://dx.doi.org/10.1016/j.theriogenology.2012.03.030ences reproductive processes, mainly by regulating pi-
tuitary gonadotropin synthesis and release, which in
turn modulate steroidogenesis and gametogenesis [1].
Continuous exposure to GnRH reduces its secretion
by downregulating GnRH receptors; this has been used
for reversible contraception [2]. In females, exogenous
nRH agonists initially causing a gonadotropin release,
hich enhances folliculogenesis and may cause ovula-ion, followed by downregulation and ovarian quies-
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ported as contraceptive in female felids: leuprolide
[4,5], deslorelin acetate [3] and azagly-naferalin [6].
Munson, et al. [3] reported for the first time the use
of deslorelin acetate (6 mg per animal) as contraceptive
in domestic queens. In that study, treated females re-
mained in anestrus for up to 14 mo. Although GnRH
agonists have been described as a reversible contracep-
tive, few studies have specifically demonstrated revers-
ibility. Returns to estrus following the use of deslorelin
acetate have been considered asynchronous [3]. Acker-
mann, et al. [7] treated queens for 60 days with deslo-
relin acetate (4.7 mg) and reported that they return to
normal cyclicity, on average, 42 days after implant
removal.
In clouded leopard (Neofelis nebulosa) females,
only one of seven animals ovulated and developed a
normal luteal phase after two injections of leuprolide
acetate (3.75 mg/animal) were given for contraception
[5]. The authors considered this response inconsistent
and attributed it to a severe ovarian alteration and
desensitization to hormonal stimulation. This was not
expected, because clouded leopards are known for their
hypersensitivity to exogenous gonadotropins.
Inconsistent responses were not restricted to feline
females [3,8]; similar results have already been de-
scribed in other species, including dogs [9,10] and
iraffes (Giraffa camelopardalis) [11]. When treated
ith GnRH agonists, common brushtail possum (Tri-
hosurus vulpecula) had an estrous cycle and preg-
ancy, with variations among individual animals in the
nterval needed to restore cyclicity [12].
The first estrus and ovulation induction after 60 days
f treatment with deslorelin acetate (4.7 mg/animal) in
omestic cats was reported recently [7]. In that study,
o ovarian desensitization to hormonal stimulation oc-
urred, despite the efficacy of the contraceptive treat-
ent. Thus, further studies assessing ovarian activity
eturn and ovulation after deslorelin acetate contracep-
ive treatment should be conducted.
The aim of this study was to evaluate ovarian activ-
ty after short-term contraceptive treatment with deslo-
elin acetate in queens.
. Materials and methods
.1. Animals
Ten mature mixed-breed queens (2–3 yrs old) were
ept in an experimental cattery at the Department of
eterinary Surgery and Anesthesiology, Faculty of
eterinary Medicine and Animal Science, FMVZ, tnesp, Botucatu, SP, Brazil. There was 12 h light/day,
ith at least 150-lux intensity. The animals were fed
ommercial cat food (Royal canine Queen 34 Royal
anine, Descalvado, SP, Brazil) and water ad libitum.
efore the study began, all cats were vaccinated against
ommon feline viruses (feline herpesvirus, feline cali-
ivirus, feline panleukopenia) and rabies. Ultrasonog-
aphy was used for the general examination of repro-
uctive tracts.
.2. Estrus cycle monitoring
In all females, the estrous cycle was evaluated by
aginal cytology (VC) and behavior observations,
onducted every 72 h by one trained observer, at
900 to 1000. Estrous signs were detected by manual
timulation of the hindquarters for 5 to 10 min. For
he procedure, each queen was individually placed on
table and hindquarters were stimulated manually.
he signs observed were tail deflection, spinal flex-
on, rubbing or rolling, vaginal discharge, vocaliza-
ion, treading of the hind legs, body or tail tremor
nd rigidity, and any striking out, clawing and
cratching, or obvious discomfort on manipulation
grunting and escape attempt).
For VC, females were physically restrained and the
ulva region was cleaned with dry gauze. Then, a
ynecologic brush was introduced cranially in the vag-
nal canal and delicately rotated. The material collected
as transferred to a glass slide, stained with rapid
anotic (Panotico Rápido LB Laborclin Produtos Para
aboratórios, Ltda, Pinhais, PR, Brazil) and evaluated
nder light microscopy (200 or 400 x). One hundred
ells were classified according to criteria proposed by
ohnston, et al. [13].
.3. Short-term contraceptive treatment
When queens had VC characteristic of interestrus or
iestrus (Day 0) evidenced by 70% superficial epi-
helial cells, the queens were anesthetized with ket-
mine hydrochloride (15 mg/kg im; Dopalen, Vet-
rands do Brasil, Paulínia, SP, Brazil) and xylazine
ydrochloride (1 mg/kg im; Xilazin, Syntec do Brasil,
otia, SP, Brazil). A deslorelin acetate implant (Supre-
orin, Peptech Animal Health Pty, Limited, NSW, Aus-
ralia; 4.7 mg/animal) was inserted in the subcutaneous
issue of the interscapular region (the area had been
haved and cleaned). After implant insertion, VC was
erformed every 48 h. On Day 90, the females were
gain anesthetized and the implants were removed
hrough an incision on the interscapular region.
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On Day 100, queens received a single injection of
eCG (100 IU im; Novormon, Bioniche, Belleville, ON,
Canada) to induce estrus and 84 h later (Day 103.5), an
injection of hCG (100 IU im; Vetecor, Laboratorios
Calier, Spain) to induce ovulation [14].
2.5. Oocyte recovery and viability
At Day 106 the females were ovariohysterecto-
mized. The oviducts were flushed with Dulbecco phos-
phate buffered saline (DPBS; Nutricell, São Paulo, SP,
Brazil) at 38 °C and the fluid recovered was observed
under a stereomicroscope. Oocytes were isolated and
stained with bisbenzimide (Hoechst 33 342) and pro-
pidium iodide (Sigma-Aldrich, Seelze, Germany) and
viability assessed with fluorescent microscopy (Leica
DM LB - blue Filter 535 and 617 nm); oocytes with
blue fluorescence were considered viable. Corpora
lutea (CL) were counted and the oocyte recovery rate
was calculated: number of oocytes identified/number of
CL x 100.
2.6. Blood collection and hormonal assays
In all queens, blood collection was done once a
week, from Days 21 to 106. Blood was centrifuged
(3000g for 15 min) and plasma was transferred to 1.5
mL Eppendorf tubes and stored at 20 °C pending
analysis. Plasma progesterone (P4) concentrations were
measured by a solid-phase RIA kit (Coat-A-Count kit,
Diagnostics Products Corporation, Los Angeles, CA,
USA), validated for domestic cats [15]. Ovulations
were confirmed when plasma P4 concentrations ex-
ceeded 1 ng/mL. The intraassay variation coefficient
was 6.84% and sensitivity was 0.0001 ng/mL.
2.7. Statistical analyses
No formal analyses were done. Data were shown
as mean  SEM, except plasma P4 concentrations
(mean  SD).
3. Results
3.1. Short-term contraceptive treatment
At the time of implant insertion, five queens were in
diestrus, whereas the other five were in interestrus;
therefore, half of the queens had spontaneous ovulation.
After deslorelin acetate application, no reaction at the
application site was observed. Insertion of the implant
under anesthesia ensured safe and accurate placement
with minimal discomfort. One queen subsequently de-veloped a mild pyodermatitis at the insertion site be-
cause of scratching.
Four females had VC and typical estrus behavior
starting 3.8  2.2 days after implant application, with
clinical signs of estrus persisting for 3.5  3.1 days.
Only one of these females subsequently had increased
plasma P4 concentrations, indicating that ovulation had
occurred after implant application. Three other queens
had increased plasma P4 concentrations, but did not
have VC consistent with estrus or typical estrus behav-
ior. Overall, 40% females ovulated after deslorelin ac-
etate short-term contraceptive treatment. The luteal
phase lasted at least 5 wk in all queens that ovulated,
before or after deslorelin treatment.
After initial ovarian stimulation, there were no ad-
ditional signs of estrus or ovulations; all females had
anestrous VC for the remainder of the short-term con-
traceptive treatment period. Plasma P4 concentrations
from Days 21 to 106 are shown (Fig. 1).
3.2. Implant removal and induction of estrus and
ovulation
Implants were readily identified and removed with-
out fragmentation, with minimal scar tissue formation.
All queens responded positively to the estrus and ovu-
lation induction protocol, with estrous VC (70% su-
perficial epithelial cells), typical estrus behavior (tail
deflection, spinal flexion, rubbing or rolling, vaginal
discharge, vocalization, treading of the hind legs, body
or tail tremor and rigidity) and ovulation (Fig. 1) fol-
lowing treatment with exogenous gonadotropins.
3.3. Oocyte recovery and viability
On average, each queen had 13.1  5.5 CL and
8.1  5.5 oocytes. In one female, in addition to the
oocytes, two two-cell embryos and one four-cell em-
bryo (Fig. 2) were also recovered, although this female
had no direct contact with tom cats. The mean oocyte
recovery rate was 56.8  25.4% and all oocytes were
viable.
4. Discussion
In the present study, deslorelin acetate effectively
suppressed cyclicity in the domestic cat. Furthermore,
after 90 days of treatment, ovarian activity was re-
established, with induction of estrus and ovulation and
recovery of viable oocytes.
Although domestic cats are known to be induced
ovulators, spontaneous ovulation has been reported
[16]. Young queens that live in groups [17] and vaginal
IU hCG
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[18]; we inferred that these factors were responsible for
the high rate (50%) of spontaneous ovulation before
short-term contraceptive treatment.
Initial ovarian stimulation, resulting in estrous VC and
typical estrous behavior in four queens, was expected,
since it was previously reported in various feline species
[8,19]. Munson, et al. [3] reported increased estradiol
Fig. 1. Mean and SD plasma progesterone concentrations in domesti
(Days 0–90), was given 100 IU eCG on Day 100, followed by 100
Fig. 2. Oocytes, two-cell embryos (black arrow) and a four-cell
embryo (white arrow) recovered from one queen previously treated
with deslorelin acetate and subsequently given eCG and hCG to
induce estrus and ovulation.concentrations resulting from ovarian stimulation soon
after treatment with deslorelin acetate. In the present
study, characteristic estrous VC and behavior were ob-
served only in four of 10 queens, but only one of these cats
ovulated. Paradoxically, three of the remaining six queens
without signs of estrus also ovulated. It is noteworthy that
high plasma estrogen concentrations in cats are not con-
sistently accompanied by estrous behavior [20].
Two queens with signs of estrus that did not ovulate
were in diestrus at implant insertion; we inferred that this
accounted for their failure to ovulate after deslorelin ace-
tate treatment. Ovarian follicular growth during diestrus
has been reported in queens [21]. Although luteal failure
was observed in bitches treated with deslorelin acetate
[22], treatment with deslorelin acetate did not shorten the
luteal phase in queens in the present study. However more
studies are needed to elucidate whether luteal failure dur-
ing pregnancy may occur in domestic queens after con-
traceptive treatment with GnRH agonists.
All queens remained in ovarian quiescence after 20
days from implant insertion, indicating that deslorelin
acetate successfully suppressed the ovarian activity and
can be used has a short-term contraceptive in domestic
cats. This result was similar to previous reports [3,19].
In the present study, removal of the deslorelin ace-
tate implants, followed by exogenous gonadotropins,
resulted in ovulation in all queens. This protocol caused
superovulation, with more CL than previously de-
scribed for domestic queens [23]. This response was
attributed to the temporary suppression of reproductive
activity, because a quiescent ovary stimulated by exog-
enous gonadotropins is more likely to respond with a
s (n  10 for all data points). Each queen had a deslorelin implant
on Day 103.5, and ovariohysterectomy on Day 106.c queenpredictable number of ovulations [5].
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821C.L. Ackermann et al. / Theriogenology 78 (2012) 817–822Since 2001, some authors have been using GnRH
agonists as a reversible contraceptive. However, few
studies have demonstrated reversibility. Severe ovarian
desensitization to eCG/hCG treatment in clouded leop-
ards treated with leuprolide acetate for a shorter interval
has been described [5]. This was particularly notewor-
thy, because the leuprolide acetate is less potent than
the deslorelin acetate and the clouded leopard is hyper-
sensitive to eCG/hCG treatment.
Recovery of embryos was observed in one female,
although there was no contact with tom cats. Therefore,
we inferred that this was due to spontaneous oocyte
activation. In that regard, parthenogenesis in cats has
been described, with a rate varying from 2 to 35.5%
[24,25].
This is apparently the first report of oocyte recovery
and viability after short-term contraceptive treatment
with deslorelin acetate in domestic cats. Further studies
should be conducted to determine if treatment duration
affects oocyte viability and recovery rate, as well as the
embryonic potential development of these oocytes.
In conclusion, deslorelin acetate can be used as a
reversible short-term contraceptive in domestic cats,
because it was possible to successfully induce estrus
and ovulation in this species.
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